Cargando…

Alpha-1-Antitrypsin Enhances Primary Human Macrophage Immunity Against Non-tuberculous Mycobacteria

Rationale: The association between non-tuberculous mycobacterial lung disease and alpha-1-antitrypsin (AAT) deficiency is likely due, in part, to underlying emphysema or bronchiectasis. But there is increasing evidence that AAT itself enhances host immunity against microbial pathogens and thus defic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bai, Xiyuan, Bai, An, Honda, Jennifer R., Eichstaedt, Charles, Musheyev, Ariel, Feng, Zhihong, Huitt, Gwen, Harbeck, Ronald, Kosmider, Beata, Sandhaus, Robert A., Chan, Edward D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606736/ https://www.ncbi.nlm.nih.gov/pubmed/31293581 http://dx.doi.org/10.3389/fimmu.2019.01417

Ejemplares similares

Differential Responses by Human Macrophages to Infection With Mycobacterium tuberculosis and Non-tuberculous Mycobacteria
por: Feng, Zhihong, et al.
Publicado: (2020)

Alpha-1-antitrypsin antagonizes COVID-19: a review of the epidemiology, molecular mechanisms, and clinical evidence
por: Bai, Xiyuan, et al.
Publicado: (2023)

Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19
por: Bai, Xiyuan, et al.
Publicado: (2021)

Improving the Lives of Patients with Alpha-1 Antitrypsin Deficiency
por: Sandhaus, Robert A, et al.
Publicado: (2020)

Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19
por: Bai, Xiyuan, et al.
Publicado: (2022)

Characterization of Immune Cells From the Lungs of Patients With Chronic Non-Tuberculous Mycobacteria or Pseudomonas aeruginosa Infection
por: Schenkel, Alan R., et al.
Publicado: (2022)

Author Correction: Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19
por: Bai, Xiyuan, et al.
Publicado: (2022)

New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency
por: Chorostowska-Wynimko, Joanna, et al.
Publicado: (2020)

Alpha 1 Antitrypsin Therapy in Patients with Alpha 1 Antitrypsin Deficiency: Perspectives from a Registry Study and Practical Considerations for Self-Administration During the COVID-19 Pandemic
por: Herth, Felix J F, et al.
Publicado: (2021)

Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency
por: Belchamber, Kylie B R, et al.
Publicado: (2020)

An analysis of the degree of concordance among international guidelines regarding alpha-1 antitrypsin deficiency
por: Attaway, Amy, et al.
Publicado: (2019)

Environmental, occupational, and genetic risk factors for alpha-1 antitrypsin deficiency.
por: Sharp, Richard R, et al.
Publicado: (2003)

Risk factors for symptom onset in PI*Z alpha-1 antitrypsin deficiency
por: Mayer, Annyce S, et al.
Publicado: (2006)

Detection of alpha-1 antitrypsin deficiency: the past, present and future
por: Brantly, Mark, et al.
Publicado: (2020)

Gene therapy for alpha 1-antitrypsin deficiency with an oxidant-resistant human alpha 1-antitrypsin
por: Sosulski, Meredith L., et al.
Publicado: (2020)

MicroRNA-155 Modulates Macrophages’ Response to Non-Tuberculous Mycobacteria through COX-2/PGE2 Signaling
por: Yuan, Zhihong, et al.
Publicado: (2021)

The Relationship between Plasma Alpha-1-Antitrypsin Polymers and Lung or Liver Function in ZZ Alpha-1-Antitrypsin-Deficient Patients
por: Sark, Annelot D., et al.
Publicado: (2022)

Characterizing Non-Tuberculous Mycobacteria Infection in Bronchiectasis
por: Faverio, Paola, et al.
Publicado: (2016)

Methods of phenotypic identification of non-tuberculous mycobacteria
por: Bhalla, Gurpreet S., et al.
Publicado: (2018)

The Incidence of Non-Tuberculous Mycobacteria in Infants in Kenya
por: Kaguthi, Grace, et al.
Publicado: (2019)

Pharmacokinetic comparability of Prolastin(®)-C to Prolastin(® )in alpha(1)-antitrypsin deficiency: a randomized study
por: Stocks, James M, et al.
Publicado: (2010)

Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency
por: Callea, Francesco, et al.
Publicado: (2018)

The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions
por: Janciauskiene, Sabina, et al.
Publicado: (2018)

Non-Tuberculous Mycobacteria Interference with BCG-Current Controversies and Future Directions
por: Verma, Deepshikha, et al.
Publicado: (2020)

Alpha-1 Antitrypsin as a Therapeutic Agent for Conditions not Associated with Alpha-1 Antitrypsin Deficiency
por: Wanner, Adam
Publicado: (2015)

Frequency of tuberculous and non-tuberculous mycobacteria in HIV infected patients from Bogota, Colombia
por: Murcia-Aranguren, Martha I, et al.
Publicado: (2001)

Inventory study of non-tuberculous mycobacteria in the European Union
por: van der Werf, Marieke J, et al.
Publicado: (2014)

Surgical Site Infections due to Non-Tuberculous Mycobacteria
por: Yadav, Rohit Prasad, et al.
Publicado: (2018)

Pulmonary non-tuberculous mycobacteria in colonisation and disease in The Gambia
por: Okoi, Catherine, et al.
Publicado: (2022)

Alpha 1 Antitrypsin-Deficient Macrophages Have Impaired Efferocytosis of Apoptotic Neutrophils
por: Lee, Jungnam, et al.
Publicado: (2020)

Association of IREB2 and CHRNA3 polymorphisms with airflow obstruction in severe alpha-1 antitrypsin deficiency
por: Kim, Woo Jin, et al.
Publicado: (2012)

HMGN2 regulates non‐tuberculous mycobacteria survival via modulation of M1 macrophage polarization
por: Wang, Xinyuan, et al.
Publicado: (2019)

Outcomes of HIV-positive patients with non-tuberculous mycobacteria positive culture who received anti-tuberculous treatment in Botswana: Implications of using diagnostic algorithms without non-tuberculous mycobacteria
por: Agizew, Tefera, et al.
Publicado: (2020)

Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency
por: Petrache, Irina, et al.
Publicado: (2009)

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
por: Chapman, Kenneth R, et al.
Publicado: (2018)

Structural characterization and conformational dynamics of alpha-1 antitrypsin pathogenic variants causing alpha-1-antitrypsin deficiency
por: Shaik, Noor Ahmad, et al.
Publicado: (2022)

Isolation of Non-Tuberculous Mycobacteria in Children Investigated for Pulmonary Tuberculosis
por: Hatherill, Mark, et al.
Publicado: (2006)

Immunological Markers of Lung Disease Due to Non-Tuberculous Mycobacteria
por: Lim, Andrew, et al.
Publicado: (2010)

Body habitus in patients with and without bronchiectasis and non-tuberculous mycobacteria
por: Schweitzer, Michael D., et al.
Publicado: (2017)

Effects of Chest Physical Therapy in Patients with Non-Tuberculous Mycobacteria
por: Basavaraj, Ashwin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_5kpihdqqiu439lomst3vhld5vl